Skip to playerSkip to main content
  • 16 minutes ago
सागर यूनिवर्सिटी के बॉयोटेक्नोलॉजी डिपार्टमेंट के रिसर्च स्कॉलर का कमाल, लहसुन के एंटी कैंसर कंपाउंड की खोज, यूके पेटेंट की तैयारी. कपिल तिवारी की रिपोर्ट.

Category

🗞
News
Transcript
00:00I don't know
00:11I don't know
00:29What is the question of this question?
00:32We know that garlic is a part of our life in our own life
00:38and we are always working on it.
00:42In the first lesson, there are many compounds for this,
00:47and we have to extract these compounds
00:52and we have to check some integrative activities
00:54and we have to check some integrative properties
01:10Yes, so what did you do with breast cancer, and what did you do with breast cancer, and what did
01:20you do with breast cancer?
01:26with some non-targeted effects, but our cell lines, which we have made,
01:37organosophore compounds, are more effective.
01:42Our normal cells have less effected, compared to conventional anti-spectrums,
01:48which are used by drugs.
01:49These are all lipid and organic.
01:53Therefore, our non-targeted cells have more harmful effects.
01:59Research has been done.
02:01Besides anti-cancerous properties,
02:05what is the use of research?
02:08What is the use of research?
02:11The lesson is very good.
02:13Everyone knows.
02:14But in the lesson, there are some things that are not absorbed in the body,
02:20and that they don't get absorbed in the body.
02:22So, our purpose is to take the first knowledge of our first knowledge,
02:28and to see which compound is very good.
02:31Especially, we have targeted anti-cancerous compounds.
02:35There are three compounds.
02:36But we have found a compound, DL-Sulfide, which comes from the lesson.
02:42But in our body, it doesn't absorb.
02:44So, we have to isolate that compound.
02:47And lipid-based, which we have made nanoparticles.
02:50Nanoparticles are very small and small.
02:52So, we have loaded this DL-Sulfide.
02:55Now, what happened?
02:56This is the targeted cancer cell line.
03:00The most important result is that we have tested in the ACTRAC in Mumbai.
03:06So, we have found that the breast cancer cell line is very easy.
03:13The second thing is that if we give antibiotics,
03:16or another compound,
03:18then it works in the other cells.
03:21But this is targeted cell cell delivery,
03:24and it works in targeted cell cell.
03:25So, we have found that anti-cancerous compounds,
03:29or anti-cancerous compounds,
03:30or anti-cancerous compounds.
03:32Now, we have been sent to publish it to this stage.
03:37We have been sent to publish it to this stage.
03:38We have been sent to this data,
03:39which is also sent to this patent.
03:42It is a good job.
03:43Our Manish Kumarmaji has done this job.
03:46And now, we are going to test this stage very quickly.
03:51So, this is a product level.
03:52we are
03:52going to be able to check the time,
03:53we are going to get homework 2 minutes.
03:54You are another one!
03:55Here,

Recommended